164 related items for PubMed ID: 11063140
1. Treatment of vasculitic IgA nephropathy.
Harper L, Ferreira MA, Howie AJ, Savage CO, Richards NT, Michael J, Adu D.
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[Abstract] [Full Text] [Related]
2. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW, Fluck RJ, Lambie SH.
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[Abstract] [Full Text] [Related]
3. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T, Lepenies J, Nightingale P, Howie AJ, Adu D, Harper L.
Nephron Clin Pract; 2009 Sep; 112(1):c16-24. PubMed ID: 19342865
[Abstract] [Full Text] [Related]
4. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
5. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D, Ahuja M, Shortland JR, Brown CB.
Nephrol Dial Transplant; 1995 May; 10(7):1173-81. PubMed ID: 7478120
[Abstract] [Full Text] [Related]
6. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[Abstract] [Full Text] [Related]
7. The spectrum of acute renal failure in IgA nephropathy.
Wen YK, Chen ML.
Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
[Abstract] [Full Text] [Related]
8. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I.
Int Urol Nephrol; 2002 May; 33(1):167-71. PubMed ID: 12090325
[Abstract] [Full Text] [Related]
9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
Medicina (B Aires); 2007 May; 67(5):445-50. PubMed ID: 18051227
[Abstract] [Full Text] [Related]
10. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
Ren Fail; 2008 May; 30(6):611-6. PubMed ID: 18661411
[Abstract] [Full Text] [Related]
11. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[Abstract] [Full Text] [Related]
12. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A.
Ren Fail; 2008 Jun; 30(6):603-9. PubMed ID: 18661410
[Abstract] [Full Text] [Related]
13. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[Abstract] [Full Text] [Related]
14. ANCA-associated crescentic IgA glomerulonephritis in pregnancy.
Amir AR, Sheikh SS.
J Nephrol; 2002 Jan; 15(6):716-9. PubMed ID: 12495291
[Abstract] [Full Text] [Related]
15. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[Abstract] [Full Text] [Related]
16. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[Abstract] [Full Text] [Related]
17. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[Abstract] [Full Text] [Related]
18. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[Abstract] [Full Text] [Related]
19. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Goumenos DS, Davlouros P, El Nahas AM, Ahuja M, Shortland JR, Vlachojannis JG, Brown CB.
Nephron Clin Pract; 2003 Dec; 93(2):C58-68. PubMed ID: 12616032
[Abstract] [Full Text] [Related]
20. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F, Pozzi C, Del Vecchio L, Andrulli S, Pani A, Fogazzi G, Altieri P, Ponticelli C.
J Nephrol; 1999 Dec; 12(5):308-11. PubMed ID: 10630693
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
